about
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesA Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasSpinal osteosarcomaGenome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor GeneExomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomasDigital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem CellsOsteosarcoma Overview.Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/BPrimary uterine osteosarcoma presenting synchronously with bilateral breast carcinomas.CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA.Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modulesmiR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1.High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma PatientsMolecular profiling of childhood cancer: Biomarkers and novel therapiesAberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma.Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma.A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma.Retrospective clinicopathological study of malignant bone tumors in children and adolescents in Romania - single center experience.Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrationsLi-Fraumeni SyndromeHeterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.The adolescent and young adult with cancer: state of the art -- bone tumors.MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.Proteomics of osteosarcoma.MicroRNAs as regulators of bone homeostasis and bone metastasis.Retrospective study on osteosarcoma and ewing sarcoma - our experience.Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines.An update on genomic-guided therapies for pediatric solid tumors.Does rarity mean imparity? Biological characteristics of osteosarcoma cells originating from the spine.Construction of recombinant pEGFP-N1-hPer2 plasmid and its expression in osteosarcoma cellsp16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.Molecular genetics of osteosarcoma.Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines.Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells.Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.Malignant transformation of fibrous dysplasia: A case report.
P2860
Q26782646-EAE5BF33-00FF-4997-8311-A3865D570CFFQ26782842-464AA95C-5A2F-479B-A51C-D1A1293A1A17Q26996533-D64094D7-6090-4E60-B478-29F674AE8638Q28554418-6A455937-CA95-48AE-86CF-A01EA3591EBBQ33554186-C00878EF-98C0-4DE2-8EB9-33C71767E3E8Q33623477-338C458A-8AB4-447C-8397-6AA2EBE083B8Q33646069-A8DD37CA-E72F-4719-87B7-2FD625A6CED2Q33722454-7879A648-7832-4DE5-A7D9-F97A820A9A3DQ33725511-0B58E658-DD3A-451D-81E9-81ECCC8743C6Q33741869-5EAD147F-39CF-4423-9FC0-72B52C004774Q33743048-0AD9E8C1-CACE-43C6-8F1E-C2B46063F030Q34629236-4C0D9B22-55F3-413B-AFC8-AA0028E844F8Q34797092-4906ACD6-3657-4011-AAFE-74D0B7F21FCCQ35010017-2C48997D-34A7-4E29-B5EF-3B506B940719Q35301939-FE43B686-FD46-41F9-8039-3C30A8AA76EFQ35808752-95BF19A0-4913-4977-AD01-931944072CF4Q36037958-331560E3-EBE9-4505-812F-7ABA69717814Q36250783-D4C41BE1-797F-4026-8970-DBEC4ECD79BCQ36301216-CC33F4AF-C07A-4363-ACE3-B3760C27AAF9Q36776382-1C660D90-0CCD-4060-AAD1-7390B93C2316Q36888962-F527CE88-132E-447F-8218-2385D81A00DAQ36891003-687CDE40-F524-4E0B-B137-F4257D27A896Q36905633-A2AFD0A1-672A-4DC8-86B3-DB01E0C7531AQ37032644-6C17D2A1-639E-4AAB-9A62-E32A44172B33Q37545406-9779FF55-D57A-40F5-8E64-D450008B2A5FQ38108248-76B31FF1-AA2E-4E95-AF75-543D525A3B16Q38116793-A976BBFB-5168-4DCF-89FA-B94633149664Q38198116-C996B7B7-37D3-44A1-A5B9-A1EE3CDD460EQ38239679-1ED6B8C7-EBA5-456D-B027-3B6EA46C56B7Q38364185-397DE24C-B3AE-4782-9754-673A4C7213F3Q38643567-26DE3467-2C37-4672-9DB0-6EDE2385A414Q38673827-18985301-743B-41B5-98FB-5E6E7CBEA47CQ38702037-C114E61F-DDCE-4BBC-9C74-F3C46B45296FQ38778601-F99814F1-5FBD-400A-9172-FD5E35C584ECQ38904937-0F2873AC-7BF0-402B-BD24-357D2DB1143FQ38985480-D2A05424-DECF-4DBD-A495-DAD4B0585CECQ39036313-785DEAA5-DA02-4774-9276-49E05411B0AFQ39129630-9819A532-9F1A-4F67-9180-516A47510D0EQ40205539-2BC83DC6-3E55-4AD2-BAB9-47B82318408DQ40893413-6F18BFBA-07F2-434D-85CA-033E7A12BF92
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The genetics of osteosarcoma.
@ast
The genetics of osteosarcoma.
@en
The genetics of osteosarcoma.
@nl
type
label
The genetics of osteosarcoma.
@ast
The genetics of osteosarcoma.
@en
The genetics of osteosarcoma.
@nl
prefLabel
The genetics of osteosarcoma.
@ast
The genetics of osteosarcoma.
@en
The genetics of osteosarcoma.
@nl
P2860
P356
P1433
P1476
The genetics of osteosarcoma.
@en
P2093
Jeff W Martin
Maria Zielenska
P2860
P304
P356
10.1155/2012/627254
P577
2012-05-20T00:00:00Z